Recombinant Vaccines Question Flashcards

1
Q

6 topics to discuss

A

Live attenuated
Recombinant subunit
Virus vector
DNA
Edible plant based
mRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Live attenuated example

A

Polio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Live attenuated

A

Weaker form of vaccine through multiple passaging at progressively lower temp
Administered mucosally typically
Mimic natural infection -> long lasting immunity

-reversion
- disease in immunocompromised host
- manufacturing and storage required stringent conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Live attenuated RSV

A

Cold adapted temperature strategy
Could not find balance between immunogenicity and pathogenicity in infants. Alternative strategy was to remove virulence factors. Research ongoing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Recombinant subunit vaccines example

A

Hep B and HPV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Recombinant subunit vaccines development

A

Identify potential antigens

First in silico B and T cell epiptope candidate identification
Pep scan for T cell proliferation
ELISA for antibody reactivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Recombinant subunit advantages

A

High safety as do not contain live or inactivated virus
Well defined, highly purified
Targeted immune response against specific antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do we combat massive strain variation in HIV?

A

Recombinant vaccine derived from multiple strains or perhaps identify an antigen that confers subtypic immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Recombinant vaccine disadvantages

A

May require adjuvants; very little choice of adjuvants; major research underway
Some viral antigens have complex structures that are challenging to produce recombinantly
Multiple doses may be required
Massive strain variation in HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What happened this week?

A

AREXVY 🥳🥳🥳🥳
83% efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

An example of a virus vector

A

SeV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Virus vector

A

Engineered viruses that can deliver viral vaccines into host cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Advantages of virus vector vaccines

A

Efficient delivery and expression of viral antigen => mimicking natural infection
Induce cellular and humoral immune responses
Can target specific cells or tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Disadvantages of virus vector vaccines

A

Pre existing immunity to vector may limit immune response
The immune response to the vector can limit subsequent vaccination
Vector production and purification is costly and time consuming

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DNA vaccines development

A

Direct introduction of plasmid DNA encoding viral vaccine antigens into host cells. Host cells produce viral antigen => immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DNA vaccine advantages

A

Simplicity in design manufacture and storage
Still in development
Can induce both humoral and cellular immune response
Rapid development and scalability

17
Q

DNA vaccine disadvantages

A

May require delivery systems and or adjuvants
Further research into safety is needed

18
Q

Edible plant based vaccines development

A

Expression of viral antigens in GMO plants which can be consumed e.g tomatoes

19
Q

Edible vaccines advantages

A

Ease of production
Scalability
Cost-effective
Eliminate need for injections
Natural exposure and mucosal immunity

20
Q

Edible vaccine disadvantages

A

Regulatory hurdles and public perceptions on GMO
Achieving high antigen expression levels is difficult and hard to maintain their stability
More work needed on efficacy and safety

21
Q

mRNA development

A

SARS-CoV-2
25 years into mRNA vaccines, 10 years into SARS/MERS spike protein research
Utilises mRNA encoding viral vaccine antigen, taken up by host cells, transcribed and triggers immune response

22
Q

mRNA vaccine advantages

A

If sequence is known vaccine can be developed easily and efficiently
Strong immune response
92% efficacy

23
Q

mRNA vaccine disadvantages

A

Labile
Needs delivery package e.g lipids
Must be stored at extremely low temps